Popular headlines in biosecurity news The Monthly Roundup is a new article featuring the top news stories from the Virtual Biosecurity Center (VBC). The VBC is a global resource for daily biosecurity news and current topics. Every month, a collection of the VBC’s most popular headlines will be summarized with a brief analysis to keep […]Read More
The U.S. Department of Health and Human Services (HHS) released its much-anticipated Guidance report on Wednesday, Oct. 13th 2010, describing a recommended screening method for synthetic double-stranded DNA (dsDNA) manufacturers. The report provides the recommended framework for the screening of orders to ensure manufacture compliance with current Select Agent Regulations (SAR) and Export Administration Regulations […]Read More
Dr. William “Bill” C. Patrick III, 84, passed away on Friday, Oct. 1, 2010. Born on July, 24, 1926 in Southhampton, SC, Patrick was a U.S. veteran and influential microbiologist that devoted over three decades of service to the U.S. Army’s headquarters for biological weapons research in Fort Detrick, MD. After serving in the Army […]Read More
The U.S. Government Accountability Office (GAO) will conduct an examination of the scientific and technical methods used by the FBI during its investigation of 2001 anthrax attacks, in response to a request made by U.S. Rep. Rush Holt (NJ-D) earlier this year. After an eight year-long investigation, the FBI closed the Amerithrax case back in […]Read More
BARDA, the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services (HHS), recently awarded four contracts for the research and development of innovative platform technologies in medical countermeasure development.
Contracts were awarded to the following organizations to continue development: the Program for Appropriate Technology in Health (PATH), the Infectious Disease Research Institute (IDRI) in Seattle, VaxDesign Corp. in Orlando and Pfenex Inc. in San Diego. A collective total of $24.6 million is allotted for initial phases and up to $53.6 million over three years.Read More
J. Craig Venter of the J. Craig Venter Institute (JCVI) in Rockville, MD announced last week that his team was able to successfully create a bacterial cell controlled by a chemically assembled, man-made genome. This breakthrough discovery in the emerging field of synthetic genomics raises some concern in the biosecurity community and prompted President Obama to […]Read More